Search Results - Chenyan Zhao

Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines by Qianqian Li, Qiang Liu, Weijing Huang, Aijing Song, Chenyan Zhao, Jiajing Wu, Youchun Wang

Connect to this object online.

Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains by Xiande Huang, Ziqi Cheng, Yake Lv, Weixuan Li, Xiaoyu Liu, Weijin Huang, Chenyan Zhao

Connect to this object online.

Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6-35 months of age in China: A randomized, double-blind, clinical trial by Shilei Wang, Yanxia Wang, Dandan Chen, Wenting Xu, Peng Duan, Wei Ji, Weijun Liu, Weijin Huang, Bing Wu, Wenqing Chai, Chenyan Zhao, Yongli Yang, Jian Luo, Dongyang Zhao, Xiuling Li

Connect to this object online.

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinica... by Jianmin Chen, Feng Jiang, Chenyan Zhao, Jing Chai, Lanshu Li, Qinghu Guan, Xiaoyu Li, Feiyu Wang, Ansheng Li, Hongxia Gao, Minghui Wang, Liandi Fu, Fei Nie, Weijun Ling, Haobin Deng, Lei Zhou

Connect to this object online.

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies by Xiaoqiang Liu, Juliana Park, Shengli Xia, Bin Liang, Shuangmin Yang, Yanxia Wang, Olga Syrkina, Nathalie Lavis, Shuzhen Liu, Chenyan Zhao, Jian Ding, Jieqiong Hu, Sandrine I. Samson, Iris A. de Bruijn, for the FSQ01 and FSQ02 Study Groups

Connect to this object online.